Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Cornblath

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Annals of Plastic Surgery|June 15, 2022
Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and ColleaguesDavid R Cornblath, Matthew C Kiernan, Jun Kimura, et al.
Clinical Drug Investigation|July 17, 2023
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with OsteoarthritisMark T Brown, David R Cornblath, Martin Koltzenburg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2019
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settingsAndreas A Argyriou, Susanna B Park, Badrul Islam, et al.
Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.
Journal of the Peripheral Nervous System : JPNS|March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathyIngemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.
Archives of Neurology|August 10, 2005
Supportive care for patients with Guillain-Barré syndromeRichard A C Hughes, Eelco F M Wijdicks, Estelle Benson, et al.
Trials|July 27, 2016
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trialIvo N van Schaik, Nan van Geloven, Vera Bril, et al.
European Journal of Neurology|September 16, 2024
Repurposing chemotherapy-induced peripheral neuropathy gradingRoser Velasco, Andreas A Argyriou, David R Cornblath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 23, 2016
Differentiating lower motor neuron syndromesNidhi Garg, Susanna B Park, Steve Vucic, et al.
Journal of the Peripheral Nervous System : JPNS|July 7, 2020
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic reviewRichard A Lewis, David R Cornblath, Hans-Peter Hartung, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Annals of Plastic Surgery|June 15, 2022
Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and ColleaguesDavid R Cornblath, Matthew C Kiernan, Jun Kimura, et al.
Clinical Drug Investigation|July 17, 2023
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with OsteoarthritisMark T Brown, David R Cornblath, Martin Koltzenburg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2019
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settingsAndreas A Argyriou, Susanna B Park, Badrul Islam, et al.
Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.
Journal of the Peripheral Nervous System : JPNS|March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathyIngemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.
Archives of Neurology|August 10, 2005
Supportive care for patients with Guillain-Barré syndromeRichard A C Hughes, Eelco F M Wijdicks, Estelle Benson, et al.
Trials|July 27, 2016
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trialIvo N van Schaik, Nan van Geloven, Vera Bril, et al.
European Journal of Neurology|September 16, 2024
Repurposing chemotherapy-induced peripheral neuropathy gradingRoser Velasco, Andreas A Argyriou, David R Cornblath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 23, 2016
Differentiating lower motor neuron syndromesNidhi Garg, Susanna B Park, Steve Vucic, et al.
Journal of the Peripheral Nervous System : JPNS|July 7, 2020
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic reviewRichard A Lewis, David R Cornblath, Hans-Peter Hartung, et al.
Pageof 10